Data / Research funding / New York / Hospital for Special Surgery
Hospital for Special Surgery: 45 NIH awards ($55.1M), fiscal years 2021 to 2026
Hospital for Special Surgery in New York, NY is funded under 45 NIH awards ($55.1M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- MKUJBCZRGUM8
- State
- New York
Awards
45 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Activation of Macrophages in Human Autoimmune Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,710,162 | March 1, 2000 | July 31, 2029 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Role of Shh/Brachyury axis in the maintenance of the postnatal intervertebral disc | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,008,731 | June 17, 2021 | March 31, 2027 | DAHIA, CHITRA L | reporter.nih.gov |
| Role of Developmental Signaling Pathways in Maintenance of Spinal Discs | NIH | National Institute on Aging | 2021 to 2024 | $2,674,109 | August 15, 2021 | April 30, 2027 | DAHIA, CHITRA L | reporter.nih.gov |
| Lymphatic regulation of lymph node function in lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,639,789 | February 1, 2010 | January 31, 2028 | LU, THERESA T. | reporter.nih.gov |
| Functional consequences of intergenic autoimmune disease risk variants | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,539,964 | March 3, 2023 | February 29, 2028 | NIEWOLD, TIMOTHY B | reporter.nih.gov |
| Post-Initiation control of transcription in inflammatory macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,363,024 | December 23, 2019 | November 30, 2025 | ROGATSKY, INEZ | reporter.nih.gov |
| Mechanisms controlling ABC differentiation and function in SLE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,285,313 | July 1, 2022 | May 31, 2027 | PERNIS, ALESSANDRA B | reporter.nih.gov |
| Inhibition of STAT3 and inflammatory cytokine production | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,211,650 | September 30, 1999 | January 31, 2027 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Glucocorticoid-regulated transcription networks in macrophage biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,201,274 | April 1, 2014 | June 30, 2030 | ROGATSKY, INEZ | reporter.nih.gov |
| Cytokine regulation of RA synoviocyte phenotype | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,930,588 | September 27, 1999 | May 31, 2027 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Regulation of bone homeostasis and remodeling by long noncoding RNA Malat1 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,795,657 | July 1, 2021 | February 28, 2027 | ZHAO, BAOHONG | reporter.nih.gov |
| Macrophages in human autoimmune tissue pathology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,780,000 | May 4, 2020 | April 30, 2026 | DONLIN, LAURA T. | reporter.nih.gov |
| Regulation of Osteoclastogenesis and Arthritic Bone Resorption by RBP-J | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,755,074 | April 1, 2017 | December 31, 2028 | ZHAO, BAOHONG | reporter.nih.gov |
| Combined Engineering and Orthopaedics Training Program | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,669,534 | June 1, 2021 | October 31, 2026 | MAHER, SUZANNE A. | reporter.nih.gov |
| Role of iRhoms and ADAM17 in EGFR and TNFalpha signaling | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,645,568 | January 1, 2020 | December 31, 2025 | BLOBEL, CARL PETER | reporter.nih.gov |
| Cytokine Balance in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,542,904 | September 10, 2004 | January 31, 2027 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Langerhans cells and lymphatic regulation in immunity | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,480,392 | August 1, 2024 | July 31, 2029 | LU, THERESA T. | reporter.nih.gov |
| HSS Research Institute Rheumatology Training | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,438,910 | May 1, 2017 | April 30, 2027 | SALMON, JANE E | reporter.nih.gov |
| Osteoclast programming and reprogramming during osteoclastogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,364,036 | September 20, 2023 | July 31, 2028 | PARK-MIN, KYUNG-HYUN | reporter.nih.gov |
| How Partial Meniscectomy Affects Contact Mechanics and Tissue Response | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,275,050 | August 12, 2019 | April 30, 2025 | MAHER, SUZANNE A. | reporter.nih.gov |
| The Ability of MRI to Detect Adverse Local Tissue Reaction and Implant Integration as a Function of Hip Implant Modularity | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $1,240,282 | August 15, 2013 | April 30, 2025 | KOFF, MATTHEW F. | reporter.nih.gov |
| Negative Regulation of Osteoclastogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,122,005 | August 1, 2024 | July 31, 2029 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Role of plasmacytoid dendritic cells in autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $880,000 | March 9, 2018 | February 29, 2024 | BARRAT, FRANCK | reporter.nih.gov |
| Negative Regulation of Osteoclastogenesis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $831,820 | September 8, 2008 | March 31, 2024 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Type I interferon Impacts Treatment Response in Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $790,560 | July 1, 2022 | June 30, 2027 | WAMPLER MUSKARDIN, THERESA | reporter.nih.gov |
| Integrated mechanobiology of tenocytes and stem cells during tendon growth | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $758,912 | August 1, 2013 | July 31, 2024 | RODEO, SCOTT A | reporter.nih.gov |
| A novel regulating pathway in osteoclastogenesis and arthritic bone resorption | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $756,427 | April 1, 2018 | January 31, 2024 | PARK-MIN, KYUNG-HYUN | reporter.nih.gov |
| Mechanisms of inflammatory osteoblastogenesis and bone formation | NIH | National Institute on Aging | 2025 | $688,634 | December 1, 2024 | November 30, 2029 | ZHAO, BAOHONG | reporter.nih.gov |
| MRI Bone Texture: A Novel Biomarker for Assessment of Bone Quality and Prediction of Complications in Patients Having Spine Fusion Surgery | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $665,177 | August 1, 2022 | May 31, 2027 | STEIN, EMILY MARGARET | reporter.nih.gov |
| SLE-AWARE: SLE-- A Window into APOL1 Regulation andExpression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $532,491 | September 20, 2021 | January 15, 2024 | BLAZER, ASHIRA DESHON | reporter.nih.gov |
| Skin-lymph node axis in SLE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $446,026 | July 15, 2022 | June 30, 2024 | LU, THERESA T. | reporter.nih.gov |
| The Regulatory Mechanisms of Osteoclasts | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $445,217 | September 1, 2025 | August 31, 2030 | PARK-MIN, KYUNG-HYUN | reporter.nih.gov |
| Tablet-Based Physical Activity Intervention for Frail and Pre-Frail Older Adults with Systemic Lupus Erythematosus | NIH | National Institute on Aging | 2024 to 2025 | $381,203 | August 15, 2024 | May 31, 2029 | LIEBER, SARAH BETH | reporter.nih.gov |
| Mechanisms of inflammatory bone remodeling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $375,584 | April 1, 2016 | January 31, 2023 | ZHAO, BAOHONG | reporter.nih.gov |
| Physical Activity Behaviors and Readiness for a Digital Health Physical Activity Intervention inOlder Adults with Systemic Lupus Erythematosus | NIH | National Institute on Aging | 2023 to 2024 | $361,640 | September 5, 2023 | May 31, 2026 | LIEBER, SARAH BETH | reporter.nih.gov |
| PTH (1-34) and pelvic fracture healing: A randomized controlled trial | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $356,297 | May 23, 2019 | March 31, 2024 | NIEVES, JERI WANZOR | reporter.nih.gov |
| Deconstructing Disparities in Lupus Pregnancies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $352,080 | July 1, 2024 | June 30, 2029 | MEHTA, BELLA | reporter.nih.gov |
| Activation of Synovial Lining Fibroblasts in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $351,920 | April 1, 2024 | March 31, 2029 | SMITH, MELANIE HENNEBRY | reporter.nih.gov |
| Discovering immune drivers of fibroblast polarization andrecovery in systemic sclerosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $351,586 | January 1, 2024 | December 31, 2028 | LAKIN, KIMBERLY SHOWALTER | reporter.nih.gov |
| Circulating cell free tumor DNA (ctDNA) in patients with immune checkpoint inhibitor associated inflammatory arthritis (ICI-IA): developing a biomarker to assess immunosuppressive drug safety | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $267,423 | September 16, 2025 | August 31, 2028 | BASS, ANNE R | reporter.nih.gov |
| Adverse pregnancy outcomes in women with systemic lupus erythematosus: improving and validating risk prediction | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $185,269 | September 1, 2020 | August 31, 2023 | SALMON, JANE E | reporter.nih.gov |
| Assessing Risk for Poor Outcomes in Antiphospholipid Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $175,373 | July 1, 2025 | June 30, 2030 | BARBHAIYA, MEDHA | reporter.nih.gov |
| TNF-alpha Blockade with Certolizumab to Prevent Pregnancy Complications in High-Risk Patients with APS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $174,810 | August 15, 2016 | June 30, 2023 | SALMON, JANE E | reporter.nih.gov |
| Origins and Functions of Intramuscular Macrophages in Duchenne Muscular Dystrophy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $162,154 | March 12, 2024 | June 30, 2025 | ZHOU, LAN | reporter.nih.gov |
| Magnetic resonance and ultrasound imaging as biomarkers for detection and monitoring of Parsonage-Turner Syndrome (PTS) | NIH | National Center for Advancing Translational Sciences | 2021 | $100,475 | April 1, 2020 | March 31, 2024 | SNEAG, DARRYL | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 26 | $13,273,042 | 0 | $0 |
| 2024 | 25 | $10,376,464 | 0 | $0 |
| 2023 | 26 | $11,820,767 | 0 | $0 |
| 2022 | 25 | $10,089,918 | 0 | $0 |
| 2021 | 24 | $9,504,903 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Clinical Research
- Autoimmune Disease
- Genetics
- Arthritis
- Lupus
- Rheumatoid Arthritis
- Women's Health
- Aging
- Prevention
- Biotechnology
- Osteoporosis
- Rare Diseases
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.